The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 6 rounds in the feed, most often in Biotech.
Venture capitalysioscapital.comRounds from 2017-05-22 to 2026-09-23
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Anaconda Biomed A Barcelona stroke-device company | Funding round Verified against 4 of 18 sources | $56M | 2026-09-23 | [ PART ] |
SpliceBio SpliceBio develops next-generation gene therapies using their proprietary Protein Splicing platform, targeting diseases caused by mutations in large genes. | Series B Verified against 1 of |
| $135M |
| 2025-06-11 |
| [ PART ] |
Neurona Therapeutics Cell therapies for targeted repair of dysfunctional neural circuits underlying chronic neurological diseases. | Funding round Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $102M | 2025-04-03 | [ PART ] |
Neurona Therapeutics Cell therapies for targeted repair of dysfunctional neural circuits underlying chronic neurological diseases. | Seed Developing, 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $120M | 2024-02-08 | [ PART ] |
SpliceBio SpliceBio develops next-generation gene therapies using their proprietary Protein Splicing platform, targeting diseases caused by mutations in large genes. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $56.9M | 2022-02-16 | [ LEAD ] |
Anaconda Biomed A Barcelona stroke-device company | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $16.9M | 2017-05-22 | [ LEAD ] |